The company intends to achieve this goal through the following means:
Constant improvement of its pharmaceutical products’ technical performance
Constant research and development of drugs that are affordable, available and ethical.
Alongside its core activities, development of new technologies and/or products to
support sustainable health care and public health safety.
Increase sales to an annual value of 125 million dollars in the
next 10 years through development of products &
services and channels across Africa, Europe and Asia.